Montergy-L Tablet is a combination medication comprising levocetirizine (5mg) and montelukast (10mg), indicated for the treatment of chronic spontaneous urticaria and allergic rhinitis. The levocetirizine component is a potent histamine receptor antagonist, effective in alleviating symptoms of urticaria, including pruritus, erythema, and angioedema. The montelukast component is a leukotriene receptor antagonist, which helps to prevent the release of pro-inflammatory mediators, thereby reducing the severity of allergic rhinitis symptoms, such as rhinitis, conjunctivitis, and sinusitis. Montergy-L Tablet provides a comprehensive approach to managing these conditions by addressing both the histamine-mediated and leukotriene-mediated pathways. The tablet is suitable for adult patients, including those with mild, moderate, or severe chronic spontaneous urticaria, and those with seasonal or perennial allergic rhinitis. Montergy-L Tablet is taken once daily, with the option to adjust the dose based on patient response and tolerability. Its efficacy and safety profile make it a valuable addition to the armamentarium of medications for treating these common and debilitating conditions.